Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults

Background: An acellular Pertussis (aP) vaccine containing recombinant genetically detoxified Pertussis Toxin (PTgen), Filamentous Hemagglutinin (FHA) and Pertactin (PRN) has been developed by BioNet-Asia (BioNet). We present here the results of the first clinical study of this recombinant aP vaccin...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Hum Vaccin Immunother
Autori principali: Sirivichayakul, Chukiat, Chanthavanich, Pornthep, Limkittikul, Kriengsak, Siegrist, Claire-Anne, Wijagkanalan, Wassana, Chinwangso, Pailinrut, Petre, Jean, Hong Thai, Pham, Chauhan, Mukesh, Viviani, Simonetta
Natura: Artigo
Lingua:Inglês
Pubblicazione: Taylor & Francis 2016
Soggetti:
Research Papers
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5287298/
https://ncbi.nlm.nih.gov/pubmed/27686283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2016.1234555
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi